These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Primary Malignant Gastrointestinal Stromal Tumor (GIST) of the Gallbladder: Report of a Case. Bolanaki H; Delladetsima I; Argyropoulou P; Kapranou A; Kakolyris S; Simopoulos C; Karayiannakis AJ J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S151-5. PubMed ID: 22086710 [No Abstract] [Full Text] [Related]
6. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Dematteo RP; Heinrich MC; El-Rifai WM; Demetri G Hum Pathol; 2002 May; 33(5):466-77. PubMed ID: 12094371 [TBL] [Abstract][Full Text] [Related]
7. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Miettinen M; Majidi M; Lasota J Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
9. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Demetri GD Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773 [TBL] [Abstract][Full Text] [Related]
10. Malignant gastrointestinal stromal tumor of the gallbladder. Park JK; Choi SH; Lee S; Min KO; Yun SS; Jeon HM J Korean Med Sci; 2004 Oct; 19(5):763-7. PubMed ID: 15483360 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases. Koay MH; Goh YW; Iacopetta B; Grieu F; Segal A; Sterrett GF; Platten M; Spagnolo DV Pathology; 2005 Feb; 37(1):22-31. PubMed ID: 15875730 [TBL] [Abstract][Full Text] [Related]
12. The histopathological differential diagnosis of gastrointestinal stromal tumours. Graadt van Roggen JF; van Velthuysen ML; Hogendoorn PC J Clin Pathol; 2001 Feb; 54(2):96-102. PubMed ID: 11215292 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE; Kim MA; Lee HS; Lee BL; Kim WH J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Miettinen M; Lasota J Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Lasota J; Miettinen M Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355 [TBL] [Abstract][Full Text] [Related]
18. Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate. Rausch JL; Boichuk S; Ali AA; Patil SS; Liu L; Lee DM; Brown MF; Makielski KR; Liu Y; Taguchi T; Kuan SF; Duensing A Oncotarget; 2017 Jan; 8(3):4471-4483. PubMed ID: 27965460 [TBL] [Abstract][Full Text] [Related]
19. GEIS guidelines for gastrointestinal sarcomas (GIST). Poveda A; García Del Muro X; López-Guerrero JA; Cubedo R; Martínez V; Romero I; Serrano C; Valverde C; Martín-Broto J; Cancer Treat Rev; 2017 Apr; 55():107-119. PubMed ID: 28351781 [TBL] [Abstract][Full Text] [Related]
20. [Imatinib--a breakthrough in the treatment of gastrointestinal stromal tumors (GIST)]. Larsen JB Ugeskr Laeger; 2003 Sep; 165(37):3503-7. PubMed ID: 14531349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]